Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Completed · Phase 3
Conditions studied: Breast Cancer
In brief
RATIONALE: The MAP.3 study was designed to test whether hormone therapy using exemestane may prevent breast cancer by blocking the production of estrogen. PURPOSE: The study protocol was amended in May 2011 and the current purpose of the study is to allow all study participants the opportunity to complete 5 years of exemestane.
Key facts
- Study ID
- NCT00083174
- Run by
- NCIC Clinical Trials Group
- People needed
- 4560
- Starts
- 2004-12-03
- Expected to finish
- 2018-01-22
- Last updated by the study team
- 2023-08-25
Who can join
Age: 35 and older. Sex: female. Healthy volunteers: accepted.
Where it is running
- UAB Comprehensive Cancer Center-LNB 301 — Birmingham, Alabama, United States
- Providence Alaska Medical Center — Anchorage, Alaska, United States
- University of California, San Diego — La Jolla, California, United States
- University of California at Davis — Sacramento, California, United States
- Los Angeles Biomedical Research Institute — Torrance, California, United States
- University of Connecticut Health Center — Farmington, Connecticut, United States
- Whittingham Cancer Center at Norwalk Hospital — Norwalk, Connecticut, United States
- The George Washington University — Washington D.C., District of Columbia, United States
- Mayo Clinic Jacksonville — Jacksonville, Florida, United States
- University of Miami School of Medicine — Miami, Florida, United States
- Georgia Cancer Specialists — Tucker, Georgia, United States
- John H. Stroger, Jr Hospital of Cook County — Chicago, Illinois, United States
- Mercy Hospital and Medical Center — Chicago, Illinois, United States
- The University of Chicago Medical Center — Chicago, Illinois, United States
- Loyola University Medical Centre — Maywood, Illinois, United States
- Trinity Medical Center — Moline, Illinois, United States
- Mid-Illinois Hematology and Oncology Associates, Ltd. — Normal, Illinois, United States
- Carle Cancer Centre — Urbana, Illinois, United States
- Indiana University Medical Center — Indianapolis, Indiana, United States
- University of Kansas Medical Center — Kansas City, Kansas, United States
- Maine Center for Cancer Medicine and Blood Disorders — Scarborough, Maine, United States
- Suburban Hospital Cancer Program — Bethesda, Maryland, United States
- MedStar Health Research Institute — Hyattsville, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Jefferson Clinic, P.C. — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.